James R. Tysome
Papers
2
Total Citations
84
H-Index
2
About
James R. Tysome is a leading clinician-scientist in head and neck surgical oncology, with a focused expertise in minimally invasive surgical approaches for oropharyngeal carcinoma. His major contributions center on evaluating the comparative effectiveness of transoral robotic surgery (TORS) and transoral laser microsurgery against radiotherapy and chemoradiotherapy for early-stage and small-volume oropharyngeal cancers. His seminal 2016 study, cited over 80 times, provides critical evidence on outcomes for human papillomavirus-associated oropharyngeal squamous cell carcinoma, a disease increasingly affecting younger patients. This work has helped shape treatment paradigms by weighing surgical morbidity against radiation toxicity. Tysome’s research is particularly impactful in the context of rising HPV-related oropharyngeal cancer incidence, where his findings guide personalized treatment decisions. His 2014 Cochrane protocol further underscores his commitment to rigorous evidence synthesis in this rapidly evolving field. Through these contributions, Tysome has advanced the understanding of how to optimize oncologic and functional outcomes, making him a key figure in the shift toward de-escalation and tailored therapy in head and neck cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2